Rybarczyk, A.; Majchrzak-Celińska, A.; Piwowarczyk, L.; Krajka-Kuźniak, V.
The Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib. Pharmaceutics 2025, 17, 1031.
https://doi.org/10.3390/pharmaceutics17081031
AMA Style
Rybarczyk A, Majchrzak-Celińska A, Piwowarczyk L, Krajka-Kuźniak V.
The Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib. Pharmaceutics. 2025; 17(8):1031.
https://doi.org/10.3390/pharmaceutics17081031
Chicago/Turabian Style
Rybarczyk, Anna, Aleksandra Majchrzak-Celińska, Ludwika Piwowarczyk, and Violetta Krajka-Kuźniak.
2025. "The Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib" Pharmaceutics 17, no. 8: 1031.
https://doi.org/10.3390/pharmaceutics17081031
APA Style
Rybarczyk, A., Majchrzak-Celińska, A., Piwowarczyk, L., & Krajka-Kuźniak, V.
(2025). The Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib. Pharmaceutics, 17(8), 1031.
https://doi.org/10.3390/pharmaceutics17081031